A novel humanized anti-CTLA-4 antibody compared to ipilimumab in preclinical studies.

Shi, Q; Liu, YL; Yang, L; Ma, HL; Ma, WC; Sun, ZY

JOURNAL OF CLINICAL ONCOLOGY, 2019; 37 (8):